Xue Wu Song

Director of Finance/CFO chez BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD.

Health Technology

Consumer Services

Profil

Xue Wu Song is currently working as the VP, Chief Financial & Accounting Officer at Beijing Centergate Technologies (Holding) Co., Ltd.
since 2022.
Additionally, Mr. Song is also a Member-Supervisory Board at DUO Pharmaceutical Co., Ltd.
since 2016.
Mr. Song completed their undergraduate degree at Renmin University of China and their graduate degree at Beihang University.

Postes actifs de Xue Wu Song

Sociétés	Poste	Début
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD.	Director of Finance/CFO	26/08/2014
DUO Pharmaceutical Co., Ltd. DUO Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology DUO Pharmaceutical Co., Ltd. is a holding company that engages in the production of pharmaceutical products. It offers medicines in the form of tablets, capsules, injections, and granules. Its products include tramadol hydrochloride tablets and injections, pediatric paracetamol enema, Vitamin C injections, cephalexin and trimethoprim capsules, glucose injections, and lincomycin hydrochloride injections. The company was founded on December 15, 1999 and is headquartered in Jiamusi, China.	Director/Board Member	08/01/2016

Tous les postes actifs de Xue Wu Song

Formation de Xue Wu Song

Renmin University of China	Undergraduate Degree
Beihang University	Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Xue Wu Song

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées	1
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD.	Health Technology

Entreprise privées	1
DUO Pharmaceutical Co., Ltd. DUO Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology DUO Pharmaceutical Co., Ltd. is a holding company that engages in the production of pharmaceutical products. It offers medicines in the form of tablets, capsules, injections, and granules. Its products include tramadol hydrochloride tablets and injections, pediatric paracetamol enema, Vitamin C injections, cephalexin and trimethoprim capsules, glucose injections, and lincomycin hydrochloride injections. The company was founded on December 15, 1999 and is headquartered in Jiamusi, China.	Health Technology